KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test
Introduction
The KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test is designed to identify genetic mutations that may lead to benign neonatal seizures. This test is crucial for early diagnosis and management of neurological disorders in newborns, providing insights that can guide treatment options.
What the Test Measures
This genetic test uses Next Generation Sequencing (NGS) technology to detect mutations in the KCNQ3 gene. These mutations are linked to benign neonatal seizures, allowing for a precise diagnosis and tailored management strategies.
Who Should Consider This Test
Newborns experiencing seizures, particularly those with a family history of KCNQ3 gene-related disorders, should be considered for this test. Symptoms to look out for include:
- Seizures occurring within the first few days of life
- Family history of seizures or epilepsy
- Neurological symptoms such as abnormal movements
Benefits of Taking the Test
- Early identification of genetic causes of seizures
- Informed treatment decisions and management options
- Guidance for family planning through genetic counseling
- Reduction of unnecessary treatments and hospitalizations
Understanding Your Results
Results will provide information on whether a mutation in the KCNQ3 gene is present. A positive result indicates a genetic cause for the seizures, while a negative result can help rule out this specific disorder. Consultation with a neurologist or genetic counselor is recommended for result interpretation and further action.
Test Details
| Test Name | Price (NGN) |
|---|---|
| KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test | Discount Price: 400,000 NGN |
| Regular Price: 560,000 NGN |
Booking the Test
To book the KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and any inquiries you may have.
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood or extracted DNA, or even one drop of blood on an FTA card. It is recommended to have a genetic counseling session to discuss the clinical history of the patient and to create a pedigree chart of family members affected with KCNQ3 Gene Seizures.
For more information or to schedule a consultation with a neurologist, please reach out to us.
